DeepMed Research

Chinese Academy of Medical Sciences Peking Union Medical College Hospital

🇨🇳China

Country: 🇨🇳China

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Efficacy of IST Combined With TPO-RA in the Treatment of AA and Establishment of a Recurrence Prediction System

Phase 4

Recruiting

Conditions: Drug Therapy
CSA
Aplastic Anemia

Interventions: Drug: CsA+ATG+Herombopag
Drug: CsA+Herombopag

First Posted Date: 2023-08-24

Last Posted Date: 2023-08-24

Lead Sponsor: Peking Union Medical College Hospital

Target Recruit Count: 210

Registration Number: NCT06009965

Locations: 🇨🇳
Peking union medical college hospital, Beijing, China

A Prospective Cohort Study of Myasthenia Gravis in China

Recruiting

Conditions: Myasthenia Gravis

Interventions: Drug: Steroid Drug
Other: Withdraw all immunosuppresants

First Posted Date: 2023-08-23

Last Posted Date: 2024-01-12

Lead Sponsor: Peking Union Medical College Hospital

Target Recruit Count: 202

Registration Number: NCT06006832

Locations: 🇨🇳
Peking Union Medical College Hospital, Beijing, Beijing, China

Roxadustat Combined With Luspatercept Versus Luspatercept Monotherapy in the Treatment of Refractory MDS-RS

Phase 4

Not yet recruiting

Conditions: Myelodysplastic Syndromes

Interventions: Drug: Roxadustat
Drug: Luspatercept

First Posted Date: 2023-08-23

Last Posted Date: 2023-08-23

Lead Sponsor: Peking Union Medical College Hospital

Target Recruit Count: 62

Registration Number: NCT06006949

Locations: 🇨🇳
Peking union medical college hospital, Beijing, China

Interstitial Lung Disease Associated

Completed

Conditions: Interstitial Lung Disease

First Posted Date: 2023-08-23

Last Posted Date: 2023-08-23

Lead Sponsor: Peking Union Medical College Hospital

Target Recruit Count: 1000

Registration Number: NCT06007040

Locations: 🇨🇳
Peking Union Medical College Hospital, Beijing, Beijing, China

Disease Characteristics of IR-CAD: a Case-control Study

Recruiting

Conditions: Coronary Artery Disease
Coronary Artery Stenosis
Coronary Artery Disease Progression
Inflammation
Inflammatory Disease
Inflammation Vascular
Coronary Artery Restenosis

Interventions: Diagnostic Test: Protocol-defined Examinations

First Posted Date: 2023-08-23

Last Posted Date: 2024-11-15

Lead Sponsor: Peking Union Medical College Hospital

Target Recruit Count: 30

Registration Number: NCT06007248

Locations: 🇨🇳
Peking Union Medical College Hospital, Beijing, Beijing, China

Efficacy and Safety of CsA+AVA in the Treatment of NSAA in the Elderly

Phase 2

Recruiting

Conditions: Aplastic Anemia

Interventions: Drug: Ciclosporin
Drug: Avatrombopag

First Posted Date: 2023-08-22

Last Posted Date: 2023-12-08

Lead Sponsor: Peking Union Medical College Hospital

Target Recruit Count: 30

Registration Number: NCT06004752

Locations: 🇨🇳
Peking union medical college hospital, Beijing, China

Efficacy and Safety of Lenalidomide Combined With Azacitidine vs Azacitidine in the Treatment of MDS-RS

Phase 4

Not yet recruiting

Conditions: Myelodysplastic Syndromes

Interventions: Drug: Lenalidomide
Drug: Azacitidine

First Posted Date: 2023-08-22

Last Posted Date: 2023-08-22

Lead Sponsor: Peking Union Medical College Hospital

Target Recruit Count: 138

Registration Number: NCT06004765

Locations: 🇨🇳
Peking union medical college hospital, Beijing, China

Retrospective Study on Perioperative Safety and Quality Control Based on Real World Data

Recruiting

Conditions: Perioperative Complication

Interventions: Procedure: Screening with PSI check list

First Posted Date: 2023-08-22

Last Posted Date: 2023-08-22

Lead Sponsor: Peking Union Medical College Hospital

Target Recruit Count: 3000

Registration Number: NCT06003517

Locations: 🇨🇳
Department of Anesthesiology, Peking Union Medical College Hospital, Beijing, Beijing, China

A Prospective, Randomized, Controlled Study of rhTPO in Combination With Herombopag + CsA vs Herombopag + CsA for the Treatment of Primary TD-NSAA

Phase 4

Not yet recruiting

Conditions: Aplastic Anemia
Drug Effect

Interventions: Drug: Herombopag + CsA
Drug: rhTPO combined with Herombopag + CsA

First Posted Date: 2023-08-22

Last Posted Date: 2023-08-22

Lead Sponsor: Peking Union Medical College Hospital

Target Recruit Count: 90

Registration Number: NCT06004791

Locations: 🇨🇳
Peking union medical college hospital, Beijing, China

Comparison of Same Morning vs Previous Evening Dosing Regimen for Assessment of Quality of Bowel Preparation for Colonoscopy Under Anesthesia

Completed

Conditions: Bowel Preparation

First Posted Date: 2023-08-21

Last Posted Date: 2023-08-21

Lead Sponsor: Peking Union Medical College Hospital

Target Recruit Count: 220

Registration Number: NCT06000241

Locations: 🇨🇳
Peking Union Medical Hospital, Beijing, Beijing, China
🇨🇳
Peking Union Medical College Hospital, Beijing, China

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy